Merck & Co Inc. | TalkMarkets | Page 1

Merck & Co Inc. | TalkMarkets | Page 1

Sign Up
Sign up with:

People who follow this stock (203)

View All

Latest Posts

About This Stock More About This Stock

Merck: Surpasses Q1 Earnings And Revenue Estimates

Article By: Zacks Investment Research

Thursday, April 27, 2023 6:50 AM EDT

Merck came out with quarterly earnings of $1.40 per share.

In this article: MRK

Moderna, Merck, And A Personalized Cancer Vaccine - Updates From AACR

Article By: Bio Deep Dives

Sunday, April 16, 2023 4:39 PM EDT

Moderna and Merck presented additional data on their personalized mRNA cancer vaccine. Is this a true breakthrough in cancer vaccines?

In this article: MRNA, MRK

MRK: Chart Of The Week

Video By: Bob Lang

Thursday, April 13, 2023 4:00 PM EDT

The 20-day moving average is coming in at about 170 – 172, which is 6 above where the current price level is.

In this video: MRK

Secrets Of Great Long-Term Stock Investors

Video By: Tracey Ryniec

Sunday, March 5, 2023 5:57 PM EDT

What can the rest of us learn from Warren Buffett's long-term stock buys? Here are 5 stock ideas for long-term investors.

In this video: AXP, CVX, KO, MRK, COKE Also: VOO, BRK-A

Merck Beats Earnings Estimates

Video By: CNBC

Thursday, February 2, 2023 9:19 AM EDT

Merck came out with quarterly earnings of $1.62 per share.

In this video: MRK

$MRK

Comments Status Updates

OncoSec Raising Its Profile In Fight Against Cancer

Harry Goldstein • 9/7/2017 5:43:14 PM

I appreciate a promising investment that also helps people. Bullish on $ONCS and $MRK.

OncoSec Raising Its Profile In Fight Against Cancer

Alexis Renault • 9/6/2017 4:08:15 PM

Thanks for this info, @[Terry Chrisomalis](user:5023). Is there any sort of official partnership or cooperation between #OncoSecMedical and #Merck to use ImmunoPulse IL-12 technology in conjunction with #Keytruda? $ONCS $MRK

OncoSec Raising Its Profile In Fight Against Cancer

Dick Kaplan • 9/6/2017 4:03:09 PM

Very impressed with the #OncosSec trial results. $ONCS $MRK $BMY